Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders

Said, Samar M; Reynolds, Carol; Jimenez, Rafael E; Chen, Beiyun; Vrana, Julie A; Theis, Jason D; Dogan, Ahmet; Shah, Sejal S
February 2013
Modern Pathology;Feb2013, Vol. 26 Issue 2, p232
Academic Journal
No abstract available.


Related Articles

  • Primary Breast Amyloidosis Presenting Solely as Nonpalpable Microcalcifications: A Case Report With Review of the Literature. Ngendahayo, Placide; Faverly, Daniel; Hérin, Michel // International Journal of Surgical Pathology;Apr2013, Vol. 21 Issue 2, p177 

    Primary breast amyloidosis is a rare disease and usually occurs as unilateral or bilateral palpable masses. Primary breast amyloidosis presenting solely as microcalcifications is extremely rare. The authors report a case of a 73-year-old woman with persistent suspicious microcalcifications...

  • The transthyretin amyloidoses: advances in therapy. Dubrey, Simon; Ackermann, Elizabeth; Gillmore, Julian // Postgraduate Medical Journal;Aug2015, Vol. 91 Issue 1078, p439 

    There are two forms of transthyretin (TTR) amyloidosis: non-hereditary and hereditary. The non-hereditary form (ATTRwt) is caused by native or wild-type TTR and was previously referred to as senile systemic amyloidosis. The hereditary form (ATTRm) is caused by variant TTR which results from a...

  • Preclinical development of siRNA therapeutics for AL amyloidosis. Hovey, B M; Ward, J E; Soo Hoo, P; O'Hara, C J; Connors, L H; Seldin, D C // Gene Therapy;Dec2011, Vol. 18 Issue 12, p1150 

    Amyloid light chain (AL) amyloidosis is a rare hematologic disorder characterized by the accumulation of a misfolded monoclonal immunoglobulin (Ig) light chain (LC) as fibrillar protein deposits. Current treatments, including cytotoxic chemotherapy and immunomodulatory therapy, are directed at...

  • AL Amyloidosis. Desport, Estelle; Bridoux, Frank; Sirac, Christophe; Delbes, Sébastien; Fernandez, Béatrice; Quellard, Nathalie; Lacombe, Corinne; Goujon, Jean-Michel; Lavergne, David; Abraham, Julie; Touchard, Guy; Fermand, Jean-Paul; Jaccard, Arnaud; Bender, Sébastien // Orphanet Journal of Rare Diseases;2012, Vol. 7 Issue 1, p54 

    Abstract: Definition of the disease: AL amyloidosis results from extra-cellular deposition of fibril-forming monoclonal immunoglobulin (Ig) light chains (LC) (most commonly of lambda isotype) usually secreted by a small plasma cell clone. Most patients have evidence of isolated monoclonal...

  • Cancer drug targets Alzheimer's. Gillings, Annabel // New Scientist;11/25/95, Vol. 148 Issue 2005, p24 

    States that a drug used to treat breast cancer also reduces the size of harmful protein deposits in AL amyloidosis, a disease similar to Alzheimer. Information of protein deposits.

  • Cyclophosphamide/epirubicin.  // Reactions Weekly;10/5/2013, Issue 1472, p16 

    An abstract of the article "Breast cancer manifested by hematologic disorders," by T. Ishikawa and colleagues is presented.

  • The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Nasr, Samih H; Said, Samar M; Valeri, Anthony M; Sethi, Sanjeev; Fidler, Mary E; Cornell, Lynn D; Gertz, Morie A; Dispenzieri, Angela; Buadi, Francis K; Vrana, Julie A; Theis, Jason D; Dogan, Ahmet; Leung, Nelson // Kidney International;Mar2013, Vol. 83 Issue 3, p463 

    Little is known about the rare entities of heavy- and light-chain amyloidosis (AHL) and heavy-chain amyloidosis (AH). Here, we report the renal and hematological characteristics, pathology, and outcome of 16 patients with renal AH/AHL (5 with AH and 11 with AHL) and compare them with 202...

  • Primary Amyloidosis of the Breast Presenting as a Solitary Nodule: Case Report and Review of the Literature. Huerter, Mary E.; Hammadeh, Rasheed; Quan Zhou; Weisberg, Asher; Riker, Adam I. // Ochsner Journal;Summer2014, Vol. 14 Issue 2, p282 

    Background: Amyloidosis of the breast is an unusual diagnosis. Overall, only 2 major case series have been published in the literature since the time amyloidosis was first reported in 1973, highlighting the rare nature of this disease. Clinically, the patient may present with a breast mass or...

  • Breast cancer. Part 3: advanced cancer and psychological implications. Harmer, Victoria // British Journal of Nursing;9/25/2008, Vol. 17 Issue 17, p1088 

    This is the last article in this 3-part series on breast cancer. The previous two articles have outlined the principles behind breast awareness and breast health, detailing common benign breast diseases, types of breast cancer and staging, and treatment for breast cancer, including surgery,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics